Occurrence of intestinal microsporidia in immunodeficient patients in Poland

Małgorzata Bednarska1, Anna Bajer1, Edward Siński1

  • 1Department of Parasitology, Institute of Zoology, Faculty of Biology, University of Warsaw, Poland.

Insights

Microsporidia infections were detected in 12.5% of immunocompromised patients in Poland. These opportunistic pathogens, including Encephalitozoon intestinalis, are significant in primary immunodeficiencies and transplant recipients with diarrhea.

Area of Science:

  • Medical Parasitology
  • Infectious Diseases
  • Immunology

Background:

  • Microsporidia cause opportunistic infections, particularly severe in immunocompromised individuals like HIV/AIDS patients, children, elderly, and those with primary or medically-induced immunodeficiencies.
  • These infections can be asymptomatic in healthy hosts but pose significant risks to vulnerable populations.

Purpose of the Study:

  • To investigate the prevalence and occurrence of microsporidia in patients with primary and secondary immunodeficiencies in Poland.
  • To identify specific microsporidia species and assess their association with clinical symptoms in immunocompromised patients.

Main Methods:

  • Collected 209 fecal samples from 80 clinical patients with or without abdominal symptoms.
  • Utilized trichrome staining of fecal smears and Polymerase Chain Reaction (PCR) for microsporidia detection.
  • Identified species including Encephalitozoon intestinalis and one unidentified species.

Main Results:

  • Microsporidia were identified in 10 out of 80 patients (12.5%).
  • In children with primary immunodeficiencies (n=32), 2 (6%) were positive, one with a co-infection of Cryptosporidium meleagridis.
  • In transplant recipients (medically-induced immunosuppression, n=48), 8 (17%) tested positive for microsporidia.

Conclusions:

  • Microsporidia are important etiological agents to consider in diarrheic patients with primary immunodeficiencies or those undergoing immunosuppressive therapy.
  • This study provides the first epidemiological data on microsporidia prevalence in immunocompromised patients in Poland.
  • Early consideration of microsporidia is crucial for accurate diagnosis and management in at-risk patient groups.